EK CLINIC LTD

Company Registration Number:
11263842 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

EK CLINIC LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

EK CLINIC LTD

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 253,826 151,916
Investments:   0 0
Total fixed assets: 253,826 151,916
Current assets
Stocks: 6,552 6,552
Debtors:   169,415 169,355
Cash at bank and in hand: 111,813 124,070
Investments:   0 0
Total current assets: 287,780 299,977
Creditors: amounts falling due within one year: 4 (60,800) (48,031)
Net current assets (liabilities): 226,980 251,946
Total assets less current liabilities: 480,806 403,862
Creditors: amounts falling due after more than one year:   0 (21,476)
Provision for liabilities: 0 0
Total net assets (liabilities): 480,806 382,386
Capital and reserves
Called up share capital: 1 1
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 480,805 382,385
Shareholders funds: 480,806 382,386

The notes form part of these financial statements

EK CLINIC LTD

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 04 June 2024
and signed on behalf of the board by:

Name: E L Kelliher
Status: Director

The notes form part of these financial statements

EK CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EK CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 6 7

EK CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Tangible Assets

Total
Cost £
At 01 April 2023 192,512
Additions 141,543
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2024 334,055
Depreciation
At 01 April 2023 40,596
Charge for year 39,633
On disposals 0
Other adjustments 0
At 31 March 2024 80,229
Net book value
At 31 March 2024 253,826
At 31 March 2023 151,916

EK CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Creditors: amounts falling due within one year note

Trade creditors £ 6875 Tax £ 36932 Social security and other taxes £ 7632 Other creditors £ 3631 Directors loan accounts £ 5730